In the current study we categorised patients simply into two groups setting the cut-off value for dysadherin immunopositivity at 50%, on the ground that the mean percentage of dysadherin-positive tumour cells was 52.0±32.3% (mean±s.d.; median, 45%). The gene discussed is FXYD5; the disease is neoplasm.